Introduction

• Statement of the issues

• Meeting objectives

• Defining the patient population

• How we reached this point

• Where we need to go

• FDA’s role & focus

• Public comment

• Agenda

• Acknowledgements

Previous slide

Next slide

Back to first slide

View graphic version